These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 26164361

  • 1. HBV immunization and vaccine coverage among hospitalized children in Cameroon, Central African Republic and Senegal: a cross-sectional study.
    Bekondi C, Zanchi R, Seck A, Garin B, Giles-Vernick T, Gody JC, Bata P, Pondy A, Tetang SM, Ba M, Ekobo CS, Rousset D, Sire JM, Maylin S, Chartier L, Njouom R, Vray M.
    BMC Infect Dis; 2015 Jul 12; 15():267. PubMed ID: 26164361
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunization.
    Rey-Cuille MA, Njouom R, Bekondi C, Seck A, Gody C, Bata P, Garin B, Maylin S, Chartier L, Simon F, Vray M.
    Pediatr Infect Dis J; 2013 Oct 12; 32(10):1110-5. PubMed ID: 23694839
    [Abstract] [Full Text] [Related]

  • 3. Effect of hepatitis B vaccination on HBV-infection among school children in Yaounde; ten years after the introduction of HBV vaccine into routine Immunization Program in Cameroon.
    Nguwoh PS, Ngounouh CT, Essomba RG, Olinga PZ, Likeng JLN, Nguepidjo G, Douyong SCT, Tchoffo D, Nlend AEN, Assoumou MCO, Fokam J.
    Pan Afr Med J; 2024 Oct 12; 47():169. PubMed ID: 39036018
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hepatitis B virus (HBV) infection amongst children in Senegal: current prevalence and seroprotection level.
    Lô G, Sow-Sall A, Diop-Ndiaye H, Babacar N, Diouf NN, Daffé SM, Ndao B, Thiam M, Mbow M, Soumboundou MB, Lemoine M, Sylla-Niang M, Ndiaye O, Boye CS, Mboup S, Touré-Kane NC.
    Pan Afr Med J; 2019 Oct 12; 32():140. PubMed ID: 31303913
    [Abstract] [Full Text] [Related]

  • 7. [Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1-29 years in different epidemic regions of China in 1992 and 2014].
    Wang FZ, Zhang GM, Shen LP, Zheng H, Wang F, Miao N, Yuan QL, Sun XJ, Bi SL, Liang XF, Wang HQ.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun 06; 51(6):462-468. PubMed ID: 28592086
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.
    Mueller A, Stoetter L, Kalluvya S, Stich A, Majinge C, Weissbrich B, Kasang C.
    BMC Infect Dis; 2015 Sep 23; 15():386. PubMed ID: 26399765
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A cross-sectional serosurvey on hepatitis B vaccination uptake among adult patients from GP practices in a region of South-West Poland.
    Ganczak M, Dmytrzyk-Daniłów G, Korzeń M, Szych Z.
    BMC Public Health; 2015 Oct 16; 15():1060. PubMed ID: 26475167
    [Abstract] [Full Text] [Related]

  • 13. Low immune response to hepatitis B vaccine among children in Dakar, Senegal.
    Rey-Cuille MA, Seck A, Njouom R, Chartier L, Sow HD, Mamadou, Ka AS, Njankouo M, Rousset D, Giles-Vernick T, Unal G, Sire JM, Garin B, Simon F, Vray M.
    PLoS One; 2012 Oct 16; 7(5):e38153. PubMed ID: 22666468
    [Abstract] [Full Text] [Related]

  • 14. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC, Maine N, Pilkington J, Mendy M, Fortuin M, Bunn J, Allison L, Howard C, Hall A.
    Lancet; 1995 Apr 29; 345(8957):1089-92. PubMed ID: 7715343
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: assessment of prevalence and vaccination coverage.
    Melo LV, da Silva MA, Calçada Cde O, Cavalcante SR, Souto FJ.
    Vaccine; 2011 Jul 18; 29(32):5290-3. PubMed ID: 21605613
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Aghasadeghi MR, Velayati AA, Mamishi S, Nabavi M, Aghakhani A, Bidari-Zerehpoosh F, Haghi Ashtiani MT, Sabeti S, Banifazl M, Azimian-Zavareh F, Motevalli F, Soleymani S, Ramezani A.
    Arch Virol; 2016 Dec 18; 161(12):3405-3411. PubMed ID: 27613286
    [Abstract] [Full Text] [Related]

  • 19. Impact of hepatitis B vaccination among children in Guangdong Province, China.
    Xiao J, Zhang J, Wu C, Shao X, Peng G, Peng Z, Ma W, Zhang Y, Zheng H.
    Int J Infect Dis; 2012 Sep 18; 16(9):e692-6. PubMed ID: 22795176
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.